Search research articles
Contact Us
Filters
Showing results (131-140 of 153) with videos related to
Page
of 16
Sort By:
Human Cell
|
September 17, 2021
Increase of serum uric acid levels associated with APOE ε2 haplotype: a clinico-genetic investigation and in vivo approach
Masatsune Ogura, Yu Toyoda, Masayuki Sakiyama, et al.
International Journal of Clinical Oncology
|
March 3, 2025
The first real-world evidence on dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin followed by switch maintenance avelumab in advanced urothelial carcinoma: a propensity score-matched study
Satoru Taguchi, Taketo Kawai, Yoshiaki Kurokawa, et al.
Japanese Journal of Clinical Oncology
|
January 15, 2025
Optimization of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy for Japanese patients with urothelial carcinoma
Taketo Kawai, Yoshiaki Kurokawa, Satoru Taguchi, et al.
Human Cell
|
December 10, 2013
Common variant of leucine-rich repeat-containing 16A (LRRC16A) gene is associated with gout susceptibility
Masayuki Sakiyama, Hirotaka Matsuo, Seiko Shimizu, et al.
Scientific Reports
|
June 10, 2014
Common dysfunctional variants of ABCG2 have stronger impact on hyperuricemia progression than typical environmental risk factors
Akiyoshi Nakayama, Hirotaka Matsuo, Hirofumi Nakaoka, et al.
The Journal of Biological Chemistry
|
February 27, 2026
SLC52A1 Is a Neofunctionalized Primate Urate Transporter Enabling Intestinal Urate Secretion
Syunsuke Yamamoto, Katsuhisa Inoue, Tomoya Yasujima, et al.
Nature Communications
|
April 5, 2012
Decreased extra-renal urate excretion is a common cause of hyperuricemia
Kimiyoshi Ichida, Hirotaka Matsuo, Tappei Takada, et al.
Antioxidants (Basel, Switzerland)
|
May 10, 2020
Higher Blood Uric Acid in Female Humans and Mice as a Protective Factor against Pathophysiological Decline of Lung Function
Haruka Fujikawa, Yuki Sakamoto, Natsuki Masuda, et al.
Japanese Journal of Clinical Oncology
|
June 27, 2025
Predictive ability of the geriatric 8 screening tool for treatment completion of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy in patients with urothelial carcinoma
Yoshiaki Kurokawa, Taketo Kawai, Satoru Taguchi, et al.
Biomedicines
|
August 27, 2021
A Proposal for Practical Diagnosis of Renal Hypouricemia: Evidenced from Genetic Studies of Nonfunctional Variants of <i>URAT1/SLC22A12</i> among 30,685 Japanese Individuals
Yusuke Kawamura, Akiyoshi Nakayama, Seiko Shimizu, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 153) with videos related to
Sort By:
Page
of 16
Human Cell
|
September 17, 2021
Increase of serum uric acid levels associated with APOE ε2 haplotype: a clinico-genetic investigation and in vivo approach
Masatsune Ogura, Yu Toyoda, Masayuki Sakiyama, et al.
International Journal of Clinical Oncology
|
March 3, 2025
The first real-world evidence on dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin followed by switch maintenance avelumab in advanced urothelial carcinoma: a propensity score-matched study
Satoru Taguchi, Taketo Kawai, Yoshiaki Kurokawa, et al.
Japanese Journal of Clinical Oncology
|
January 15, 2025
Optimization of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy for Japanese patients with urothelial carcinoma
Taketo Kawai, Yoshiaki Kurokawa, Satoru Taguchi, et al.
Human Cell
|
December 10, 2013
Common variant of leucine-rich repeat-containing 16A (LRRC16A) gene is associated with gout susceptibility
Masayuki Sakiyama, Hirotaka Matsuo, Seiko Shimizu, et al.
Scientific Reports
|
June 10, 2014
Common dysfunctional variants of ABCG2 have stronger impact on hyperuricemia progression than typical environmental risk factors
Akiyoshi Nakayama, Hirotaka Matsuo, Hirofumi Nakaoka, et al.
The Journal of Biological Chemistry
|
February 27, 2026
SLC52A1 Is a Neofunctionalized Primate Urate Transporter Enabling Intestinal Urate Secretion
Syunsuke Yamamoto, Katsuhisa Inoue, Tomoya Yasujima, et al.
Nature Communications
|
April 5, 2012
Decreased extra-renal urate excretion is a common cause of hyperuricemia
Kimiyoshi Ichida, Hirotaka Matsuo, Tappei Takada, et al.
Antioxidants (Basel, Switzerland)
|
May 10, 2020
Higher Blood Uric Acid in Female Humans and Mice as a Protective Factor against Pathophysiological Decline of Lung Function
Haruka Fujikawa, Yuki Sakamoto, Natsuki Masuda, et al.
Japanese Journal of Clinical Oncology
|
June 27, 2025
Predictive ability of the geriatric 8 screening tool for treatment completion of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy in patients with urothelial carcinoma
Yoshiaki Kurokawa, Taketo Kawai, Satoru Taguchi, et al.
Biomedicines
|
August 27, 2021
A Proposal for Practical Diagnosis of Renal Hypouricemia: Evidenced from Genetic Studies of Nonfunctional Variants of <i>URAT1/SLC22A12</i> among 30,685 Japanese Individuals
Yusuke Kawamura, Akiyoshi Nakayama, Seiko Shimizu, et al.
Page
of 16